Fig. 2From: Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published dataOutcome comparison adjusted for propensity score between sing-agent and combination chemotherapy groups in the retrospective cohort: a) progression-free survival; b) overall survival. Legend: PFS, progression-free survival; OS, overall survivalBack to article page